Financial PerformanceFree cash flow was positive in the quarter, at $1.3M, with no debt on the balance sheet.
Product LaunchGenesisX, Stereotaxis’ mobile robot that can be installed in days rather than months, has launched in Europe and is expected to be FDA cleared soon.
Strategic PartnershipSTXS’s acceptance into the NVIDIA Connect program marks a pivotal milestone in its long-term innovation strategy, enabling future advanced AI integration to enhance robotic precision, automation, and decision support.